Demographic characteristics and the clinical profile of Vulvar cancer patients treated at Tikur Anbessa Specialized Hospital, a five years retrospective study
- Articles
- Submited: March 29, 2021
-
Published: September 24, 2021
Abstract
AbstractBackground: Vulvar cancer is a rare disease that occurs most often in older women; however, this is not reflected in clinical practice at Tikur Anbessa Hospital (TAH). Overall there is limited information regarding vulvar cancer in Ethiopia.
Aim: The aim of this study was to describe demographic characteristics and the clinical profile of Vulvar Cancer patients treated at Tikur Anbessa Specialized Hospital.
Methods: This is a retrospective study. Data on primary vulvar cancer patients managed between August 30 2012 and August 30 2017 were gathered from patients’ chart and analyzed.
Results: The median/mean age was 39/43.17 ranging from 22 to 85 years. The patients presented with more than one symptom. The mean duration of the symptoms was about 2 years. Labium majus(91.5%), labium minus (89%) were mainly affected. In most (79.7%) patients the disease was locally advanced. Sixty six percent of the cases were positive for HIV. The mean/ median duration of HIV infection was 72.14/72 months. All of them were taking HAART. The majority (32.2%) were treated with chemo-radiation followed by surgery alone (16.9%). A Surgical procedure was done for 22 patients. Few patients developed complications.
Conclusion: Vulvar cancer in Ethiopia appears to be a burden of mainly the young and HIV positive patients. Most present in late stage of the disease despite visiting a health care facility for HIV care/HAART and long standing symptoms. Delivering education about vulvar cancer to Patients, particularly HIV positive ones, and health care providers may ameliorate the disease burden in Ethiopia.
Downloads
References
- de Martel C, Ferlay J, Franceschi S, al. e. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15.
- Hacker NF,et al. Cancer of the vulva. Int J Gynaecol Obstet. 2015;131 76-8.
- Hampl M, al. e. New aspects of vulvar cancer: changes in localization and age of onset. Vulvar cancer in women less than fifty in United States, 1980-2005. Gynecol Oncol. 2009.
- Mary Ann Dadzie, al. e. Vulva cancer in Ghana - Review of a hospital based data. Gynecologic Oncology Reports. 2017; 108-111.
- Zongo, et al. Cancer of the vulva in Burkina Faso: a hospital-based case series. Infect Agents and Cancer 2016;11:33.
- Siddiqui N. The management of vulval cancer. Obstet Gynaecol. 2002;12 (2): 97-103.
- Mary Ann Dadzie et al. Vulva cancer in Ghana – Review of a hospital based data. Gynecologic Oncology Reports 2017;108-111.
- Thakur, et al. Clinical analysis of vulvar carcinoma. . Gynecology 2013. 2013.
- Singh DK, Anastos K, Hoover DR, ;. ea. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis. 2009;199:1851-61.
- Denny L, Boa R, Williamson AL, al. e. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol. 2008;111:1380-7.
- Brickman C, JM P. Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era. 2015.
- Hampl M, Deckers-Figiel S, Hampl JA, et al. aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2009.
- Singh, et al. A cohort study of vulvar cancer. Indian Journal of Cancer 2016;53 (3).
- Hacker NF, Eifel PJ, J vdV. FIGO cancer report 2012. Cancer of the vulva. Int J Gynecol Obstet. 2012;119 90?6.
- Okolo CA, Odubanjo MO, Awolude OA, et al. A review of vulvar and vaginal cancers in Ibadan, Nigeria. . Am J Med Sci 2013;6:76?81.
- Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst. 1997;89:1516- 23.
- Canavan TP, D. C. Vulvar cancer. Am Fam Physician. 2002;66:1269-74.
- Al-Ghamdi A et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. . Gynecol Oncol. 2002 84(1):94-101.
- Alkatout, et al. Vulvar cancer: epidemiology, clinical presentation, and management options International Journal of Women’s Health. 2015;7.
- Ahizechukwu C Eke et al. Management options for vulvar carcinoma in a low resource setting. World J Surg Oncol. 2010;8:94.
- Nkyekyer, K. Pattern of gynaecological cancers in Ghana. . East Afr Med J. 2000;77 10.
- Stroup AM et al. Demographic, Clinical, and Treatment Trends among Women Diagnosed with Vulvar Cancer in the U.S. Gynecol Oncol. 2008 108(3):577-83.
- Clemente et al. Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection:A case report Medicine (2017) 96:4 Cervical Cancer, an open access journal
- Sefinew Migbaru Abate https://www.omicsonline.org/open-access/trends-of-cervical-cancer in Ethiopia for the years 1997-2012
- Alkatout et al. Vulvar cancer: epidemiology, clinical presentation, and management options International Journal of Women’s Health 2015:7
- Stoup AM et, al. Demographic, Clinical, and Treatment Trends Among Women Diagnosed with Vulvar Cancer in the U.S. Gynecol Oncol. 2008 March; 108(3): 577–583.
- Smith et al. Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors
- Faber et al. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J Cancer. 2017 Sep 15; 141(6):1161-1169
- Siriaunkgul et al. HPV Detection and Genotyping in Vulvar Squamous Cell Carcinoma in Northern Thailand. Asian pacific Journal of Cancer Prevention. 2014, 15 (8), 3773-3778.